BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19710692)

  • 1. Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.
    Kaku H; Rothstein TL
    Genes Immun; 2010 Jan; 11(1):55-66. PubMed ID: 19710692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.
    Pfisterer P; Annweiler A; Ullmer C; Corcoran LM; Wirth T
    EMBO J; 1994 Apr; 13(7):1654-63. PubMed ID: 8157005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.
    Pfisterer P; König H; Hess J; Lipowsky G; Haendler B; Schleuning WD; Wirth T
    Mol Cell Biol; 1996 Nov; 16(11):6160-8. PubMed ID: 8887646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of specific mRNA transcripts, usage of an alternate promoter, and octamer-binding transcription factors influence the surface expression levels of the HIV coreceptor CCR5 on primary T cells.
    Mummidi S; Adams LM; VanCompernolle SE; Kalkonde M; Camargo JF; Kulkarni H; Bellinger AS; Bonello G; Tagoh H; Ahuja SS; Unutmaz D; Ahuja SK
    J Immunol; 2007 May; 178(9):5668-81. PubMed ID: 17442950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1.
    Pfisterer P; Zwilling S; Hess J; Wirth T
    J Biol Chem; 1995 Dec; 270(50):29870-80. PubMed ID: 8530384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Btk expression is controlled by Oct and BOB.1/OBF.1.
    Brunner C; Wirth T
    Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
    Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
    Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
    Grumont RJ; Richardson IB; Gaff C; Gerondakis S
    Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.
    Zhong X; Tumang JR; Gao W; Bai C; Rothstein TL
    Eur J Immunol; 2007 Sep; 37(9):2405-10. PubMed ID: 17683117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OBF1 and Oct factors control the germinal center transcriptional program.
    Song S; Cao C; Choukrallah MA; Tang F; Christofori G; Kohler H; Wu F; Fodor BD; Frederiksen M; Willis SN; Jackson JT; Nutt SL; Dirnhofer S; Stadler MB; Matthias P
    Blood; 2021 May; 137(21):2920-2934. PubMed ID: 33512466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
    Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
    J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.
    Kistler B; Pfisterer P; Wirth T
    Oncogene; 1995 Sep; 11(6):1095-106. PubMed ID: 7566969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.
    Ishida M; Iwai Y; Tanaka Y; Okazaki T; Freeman GJ; Minato N; Honjo T
    Immunol Lett; 2002 Oct; 84(1):57-62. PubMed ID: 12161284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB.
    Mueller K; Quandt J; Marienfeld RB; Weihrich P; Fiedler K; Claussnitzer M; Laumen H; Vaeth M; Berberich-Siebelt F; Serfling E; Wirth T; Brunner C
    Nucleic Acids Res; 2013 Feb; 41(4):2138-54. PubMed ID: 23293002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation.
    Aoki M; Terada T; Kajiwara M; Ogasawara K; Ikai I; Ogawa O; Katsura T; Inui K
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F165-70. PubMed ID: 18508876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system.
    Annweiler A; Zwilling S; Hipskind RA; Wirth T
    J Biol Chem; 1993 Feb; 268(4):2525-34. PubMed ID: 8428930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an Oct1 orthologue in the channel catfish, Ictalurus punctatus: a negative regulator of immunoglobulin gene transcription?
    Lennard ML; Hikima J; Ross DA; Kruiswijk CP; Wilson MR; Miller NW; Warr GW
    BMC Mol Biol; 2007 Jan; 8():8. PubMed ID: 17266766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.
    Annweiler A; Müller-Immerglück M; Wirth T
    Mol Cell Biol; 1992 Jul; 12(7):3107-16. PubMed ID: 1620119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.